Clinical risk score and FFS in NHL and HL
| Diagnosis, CliRS . | No. of patients . | Relapse rate, no. (%) . | P . | 2-y FFS, % (95% CI) . | P . |
|---|---|---|---|---|---|
| NHL | .049 | .018 | |||
| 0 | 6 | 2 (25) | 67 (48-86) | ||
| 1 | 21 | 9 (43) | 56 (45-67) | ||
| 2 | 43 | 29 (67) | 26 (18-34) | ||
| 3 | 8 | 7 (88) | 12 (1-23) | ||
| HL | .45 | .57 | |||
| 0 | 4 | 1 (25) | 75 (55-95) | ||
| 1 | 12 | 6 (50) | 47 (32-62) | ||
| 2 | 6 | 4 (67) | 50 (30-70) | ||
| 3 | 1 | 1 (100) | 0 (0-0) |
| Diagnosis, CliRS . | No. of patients . | Relapse rate, no. (%) . | P . | 2-y FFS, % (95% CI) . | P . |
|---|---|---|---|---|---|
| NHL | .049 | .018 | |||
| 0 | 6 | 2 (25) | 67 (48-86) | ||
| 1 | 21 | 9 (43) | 56 (45-67) | ||
| 2 | 43 | 29 (67) | 26 (18-34) | ||
| 3 | 8 | 7 (88) | 12 (1-23) | ||
| HL | .45 | .57 | |||
| 0 | 4 | 1 (25) | 75 (55-95) | ||
| 1 | 12 | 6 (50) | 47 (32-62) | ||
| 2 | 6 | 4 (67) | 50 (30-70) | ||
| 3 | 1 | 1 (100) | 0 (0-0) |